We are a Global New Drug Development Company. We have EC-18, our leading compound to treat chemotherapy-induced neutropenia and thrombocytopenia. EC-18 is a non-protein small molecule and oral first-in-class drug as a supplemental drug for most cancer drugs.
We are a functional health food company. We have ROCKPID, the world's first patented immune-modulatory functional health food (FHF), which was approved by the Korean FDA in December 2013.
We also develop and manufacture generic APIs (active pharmaceutical ingredients) such as cephalosporin antibiotics, anti-tuberculosis, anti-coagulant, analgesic, and so on.
